130 related articles for article (PubMed ID: 19961824)
1. Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency.
Lee HH; Lee YJ; Chao MC
Anal Biochem; 2010 Apr; 399(2):293-8. PubMed ID: 19961824
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the CYP21A2 gene with intergenic recombination and multiple gene deletions in the RCCX module.
Chang SF; Lee HH
Genet Test Mol Biomarkers; 2011; 15(1-2):35-42. PubMed ID: 21117955
[TBL] [Abstract][Full Text] [Related]
3. Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia.
Lee HH
Clin Chim Acta; 2013 Mar; 418():37-44. PubMed ID: 23313747
[TBL] [Abstract][Full Text] [Related]
4. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module.
Lee HH; Lee YJ; Lin CY
Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125
[TBL] [Abstract][Full Text] [Related]
5. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
Fanis P; Skordis N; Phylactou LA; Neocleous V
Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
[TBL] [Abstract][Full Text] [Related]
6. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
Lee HH; Tsai FJ; Lee YJ; Yang YC
Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency.
Lee HH; Lee YJ; Wang YM; Chao HT; Niu DM; Chao MC; Tsai FJ; Lo FS; Lin SJ
Mol Genet Metab; 2008 Apr; 93(4):450-7. PubMed ID: 18039588
[TBL] [Abstract][Full Text] [Related]
8. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
[TBL] [Abstract][Full Text] [Related]
9. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
[TBL] [Abstract][Full Text] [Related]
10. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
Lee HH
Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
[TBL] [Abstract][Full Text] [Related]
11. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
12. Pseudogene
Lao Q; Zhou K; Parker M; Faucz FR; Merke DP
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833192
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CYP21A1P pseudogene: indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes.
Tsai LP; Cheng CF; Chuang SH; Lee HH
Anal Biochem; 2011 Jun; 413(2):133-41. PubMed ID: 21324303
[TBL] [Abstract][Full Text] [Related]
16. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
Concolino P
Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.
Lao Q; Brookner B; Merke DP
J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome.
Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A
Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436
[TBL] [Abstract][Full Text] [Related]
19. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
[TBL] [Abstract][Full Text] [Related]
20. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
